PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. More Details
Flawless balance sheet with solid track record and pays a dividend.
Share Price & News
How has PetMed Express's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PETS is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: PETS's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
7 Day Return
US Online Retail
1 Year Return
US Online Retail
Return vs Industry: PETS underperformed the US Online Retail industry which returned 64.2% over the past year.
Return vs Market: PETS exceeded the US Market which returned 37.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is PetMed Express's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall StDoes PetMed Express' (NASDAQ:PETS) Statutory Profit Adequately Reflect Its Underlying Profit?
2 weeks ago | Simply Wall StHas PetMed Express (NASDAQ:PETS) Got What It Takes To Become A Multi-Bagger?
4 weeks ago | Simply Wall StDon't Ignore The Fact That This Insider Just Sold Some Shares In PetMed Express, Inc. (NASDAQ:PETS)
Is PetMed Express undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PETS ($36.68) is trading above our estimate of fair value ($36.28)
Significantly Below Fair Value: PETS is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: PETS is good value based on its PE Ratio (23.9x) compared to the US Online Retail industry average (32.3x).
PE vs Market: PETS is poor value based on its PE Ratio (23.9x) compared to the US market (21.7x).
Price to Earnings Growth Ratio
PEG Ratio: PETS is poor value based on its PEG Ratio (2.1x)
Price to Book Ratio
PB vs Industry: PETS is overvalued based on its PB Ratio (5.3x) compared to the US Online Retail industry average (5x).
How is PetMed Express forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PETS's forecast earnings growth (11.6% per year) is above the savings rate (2%).
Earnings vs Market: PETS's earnings (11.6% per year) are forecast to grow slower than the US market (20.3% per year).
High Growth Earnings: PETS's earnings are forecast to grow, but not significantly.
Revenue vs Market: PETS's revenue (3.4% per year) is forecast to grow slower than the US market (10.4% per year).
High Growth Revenue: PETS's revenue (3.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PETS's Return on Equity is forecast to be high in 3 years time (23.6%)
How has PetMed Express performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PETS has high quality earnings.
Growing Profit Margin: PETS's current net profit margins (9.9%) are higher than last year (9.3%).
Past Earnings Growth Analysis
Earnings Trend: PETS's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: PETS's earnings growth over the past year (20.9%) exceeds its 5-year average (6.5% per year).
Earnings vs Industry: PETS earnings growth over the past year (20.9%) underperformed the Online Retail industry 64.6%.
Return on Equity
High ROE: PETS's Return on Equity (22.1%) is considered high.
How is PetMed Express's financial position?
Financial Position Analysis
Short Term Liabilities: PETS's short term assets ($141.0M) exceed its short term liabilities ($26.9M).
Long Term Liabilities: PETS's short term assets ($141.0M) exceed its long term liabilities ($1.3M).
Debt to Equity History and Analysis
Debt Level: PETS is debt free.
Reducing Debt: PETS has not had any debt for past 5 years.
Debt Coverage: PETS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PETS has no debt, therefore coverage of interest payments is not a concern.
What is PetMed Express's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PETS's dividend (3.05%) is higher than the bottom 25% of dividend payers in the US market (1.33%).
High Dividend: PETS's dividend (3.05%) is low compared to the top 25% of dividend payers in the US market (3.7%).
Stability and Growth of Payments
Stable Dividend: PETS's dividends per share have been stable in the past 10 years.
Growing Dividend: PETS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (72.2%), PETS's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PETS's dividends in 3 years are forecast to be covered by earnings (78% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Menderes Akdag (59 yo)
Mr. Menderes Akdag has been the Chief Executive Officer of PetMed Express, Inc. since March 16, 2001 and has been its President since August 2005. Mr. Akdag has a breadth of experience in the areas of dire...
CEO Compensation Analysis
Compensation vs Market: Menderes's total compensation ($USD1.30M) is below average for companies of similar size in the US market ($USD2.20M).
Compensation vs Earnings: Menderes's compensation has increased by more than 20% in the past year.
|CEO, President & Director||19.92yrs||US$1.30m||1.68% |
|Independent Chairman of the Board||no data||US$159.85k||0.27% |
|Independent Director||18.25yrs||US$159.85k||0.41% |
|Independent Director||17.5yrs||US$159.85k||0.27% |
|Independent Director||2.58yrs||US$159.85k||0.11% |
Experienced Board: PETS's board of directors are seasoned and experienced ( 17.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: PETS insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
PetMed Express, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: PetMed Express, Inc.
- Ticker: PETS
- Exchange: NasdaqGS
- Founded: 1996
- Industry: Internet and Direct Marketing Retail
- Sector: Retail
- Market Cap: US$697.467m
- Shares outstanding: 20.09m
- Website: https://www.1800petmeds.com
Number of Employees
- PetMed Express, Inc.
- 420 South Congress Avenue
- Delray Beach
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PETS||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Sep 1997|
|PQM||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Sep 1997|
PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/02/27 00:30|
|End of Day Share Price||2021/02/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.